1. Introduction {#sec1}
===============

Invasive cryptococcal infection, or cryptococcosis, usually develops in immunocompromised hosts, e.g., in human immunodeficiency virus- (HIV-) positive patients. However, it also occurs in HIV-negative subjects. Cryptococcosis-related mortality is high and does not differ between HIV-positive and HIV-negative patients \[[@B1]\]. Although cryptococcal infection of the lungs and nervous system is common, gastrointestinal cryptococcosis can occur in the absence of infection of above organs \[[@B2]\], as innate and adaptive immune dysfunction is noted in patients with end-stage liver disease \[[@B3]\]. Thus, cryptococcal peritonitis has been reported, with some cases progressing to fungemia and/or meningitis in instances of alcoholic \[[@B4]\], hepatitis B virus (HBV) \[[@B5], [@B6]\], or hepatitis C virus (HCV) \[[@B7]\] related decompensated hepatic cirrhosis. We report here a fatal Japanese case of*Cryptococcus neoformans* fungemia related to HBV cirrhosis in an elderly patient with pleural effusion and ascites. We also reviewed previously reported similar cases in Japan.

2. Case Presentation {#sec2}
====================

An 82-year-old female was transferred to the emergency department of our hospital with general malaise followed by septic shock-like symptoms. She had been undergoing renal dialysis over the past 2 years. The patient\'s test was negative for HIV, HCV, and human T-cell leukemia virus 1, and she did not have any type of cancer, was not undergoing chemo- or corticosteroid therapy, and showed no evidence of autoimmune diseases, but she had a history of HBV infection. She was not a drinker. Prior to admission, she had been in another hospital where she was diagnosed with end-stage hepatic failure (Child-Pugh stage C) and treated for anorexia, hypotension, and hypoglycemia. On admission, the patient complained of malaise, followed by a state of Japan Coma Scale I-3 (Glasgow Coma Scale E3V1M5), with severe hypotension (blood pressure unmeasurable). She was afebrile, severely anemic, and icteric, with liver dysfunction and hemorrhagic tendency but without peritoneal signs, such as localized guarding. Laboratory tests indicated high serum C-reactive protein levels, increased direct bilirubin, and extremely high hyaluronic acid and type IV collagen levels, in association with reduced total protein and albumin levels, as well as reduced prothrombin time and markedly low choline esterase activity. All these were compatible with decompensated liver dysfunction. For the complement system, reduced 50% hemolytic complement (CH50) and C3 levels, with normal C4 levels, were noted ([Table 1](#tab1){ref-type="table"}). Abdominal computed tomography revealed pleural effusion and small ascites ([Figure 1](#fig1){ref-type="fig"}). Pleural effusion was aspirated; cell counts therein were determined to be 272/*μ*L, and the culture was negative. Abdominal paracentesis and spinal tap were not performed. During her admission, she was cared for by intubation in the intensive care unit because of persistent hypotension and low blood oxygen saturation (SpO~2~). Blood culture on admission yielded*Cryptococcus* ([Figure 2](#fig2){ref-type="fig"}) on day 4 of admission when she died. Also, positive serum cryptococcal antigen (titer; 1:128) was confirmed postmortem. Consequently, the patient was diagnosed as having invasive cryptococcal infection linked to HBV-related hepatic cirrhosis and died prior to receiving antifungal agents. Later, the presence of*C. neoformans* was confirmed.

*Survey of Reports of Japanese Cases.*We used the Igaku Chuo Zassi (ICHUSHI; the Japan Medical Abstract Society, www.jamas.or.jp) to survey data for patients in Japan who suffered from invasive cryptococcal infection related to liver cirrhosis and/or failure during the years 1990--2016. The keywords used were "liver cirrhosis", "peritonitis", "meningitis", and "systemic cryptococcal infection". Cases concurring with cancer were excluded. We identified 11 cases, mostly short abstracts and not full papers \[[@B8]--[@B18]\] ([Table 2](#tab2){ref-type="table"}). Including the case described in the current report, a total 12 cases were analyzed. Of these cases, nine patients were over 50 years old and the male/female ratio was 9/3. The following causes of liver cirrhosis were reported: HBV (n=2), HCV (n=2), alcohol (n=2), primary biliary cirrhosis (n=2), and unknown (n=4). Treatment was known for eleven cases except for one. Seven cases received antifungal agents, of which four were alive and three had died at the time of reporting. All four cases not given antifungal agents died. Although detailed information was limited in the retrieved reports, it appears that the outcome may have been better in certain cases who were diagnosed early and had the antifungal treatment been provided in a timely manner.

3. Discussion {#sec3}
=============

Alveolar macrophages are the first line of defense against*C. neoformans* infection, followed by neutrophils and monocytes. As a third line of defense, T- and B-cell responses are critical and produce various cytokines, such as interferon gamma and specific antibodies \[[@B19]\]. When such defense mechanisms break down in immunocompromised patients,*C. neoformans* emerges as an important pathogen \[[@B20]\].

Invasive cryptococcal infection such as fungemia and/or meningitis mostly occurs in association with immunocompromised conditions, such as acquired immunodeficiency syndrome, or with autoimmune diseases such as systemic lupus erythematosus and rheumatoid arthritis \[[@B21], [@B22]\]. On the other hand, in patients with decompensated hepatic cirrhosis,*C. neoformans* invades the host through the gastrointestinal tract and causes peritonitis even in HIV-negative patients \[[@B4]--[@B6], [@B20], [@B21]\]. Some of these patients have localized peritonitis, but others further develop fungemia and/or meningitis \[[@B4], [@B6]\]. Although precise mechanism remains unknown, recent reports on cirrhotic patients complicated with invasive cryptococcal infection are accumulating \[[@B8], [@B9], [@B21], [@B23]--[@B25]\].

The patient described in the current study exhibited septic shock-like symptoms on admission, with pleural effusion and ascites. Although pleural effusion as an initial clinical presentation in cryptococcosis has been reported \[[@B9], [@B23]\], the pleural fluid culture was negative in our case. During 4 days of admission with rapid deteriorating, we were unable to diagnose the disease prior to the patient\'s death. We missed the chance to detect cryptococcal antigen and beta-D-glucan in time \[[@B26]\] and failed to examine the ascites and cerebral spinal fluid, but eventually blood culture yielded*C. neoformans*. In hindsight, we speculated that the patient had already developed peritonitis and fungemia prior to referral to the hospital. This was compatible with a report that delayed diagnosis of cryptococcal peritonitis often results in death \[[@B5]\]. A report on a patient by Jean et al. \[[@B20]\] illustrates the difficulty of diagnosis, in which ascites was examined four times during 2 weeks after admission; upon fourth examination, both the ascites and serum became positive for the cryptococcal antigen. A week later, the cerebrospinal fluid culture yielded*C. neoformans*.

Including the same eight cases cited from literature, Albert-Braun et al. \[[@B4]\] analyzed 17 cases and Park et al. \[[@B6]\] analyzed 16 cases of HIV-negative cryptococcal peritonitis linked to cirrhosis. Of the 11 patients treated with amphotericin B with or without fluconazole; two patients survived \[[@B4]\], while 7 of 16 (44%) patients who did not receive antifungal treatment died \[[@B6]\]. Spec et al. reported high mortality (20/25; 80%) including 7 cases died before administration of antifungal therapy \[[@B24]\]. On the other hand, among the Japanese cases analyzed in the current study, antifungal agents were given to 7 of 12 (58%) patients, of which four were alive at the time of reporting. Unfortunately, the correlation of timing of antifungal agent administration and outcome could not be analyzed.

Early diagnosis of*C. neoformans* peritonitis is possible if India ink-positive encapsulated budding yeasts are visible upon microscopic examination of the ascites \[[@B5]\]. However, obtaining fungi from cultures of the ascites, blood, or cerebrospinal fluid takes 3--7 days. Although reports of cryptococcal peritonitis in cirrhotic patients are still limited, the incidence is likely underestimated when the physician does not recognize such a risk factor and the disease is not specifically looked for, as illustrated by the current report. When a patient presents with shock and coma, which are common clinical features of invasive cryptococcal disease \[[@B27]\], it appears to be already too late to offer life-saving treatment.

In suspected cases of cryptococcal fungemia, depletion of the serum complement components should be evaluated. Complement C3 as well as CD11b are essential for neutrophil swarming around*C. neoformans* \[[@B28]\]. The ability of the serum to mediate C3 binding to*C. neoformans* is severely impaired in patients with invasive cryptococcal infection \[[@B29]\]. In fact, in the case reported in the current study, reduced CH50 and C3 levels, with normal C4 levels, matched the data presented in a previous report \[[@B29]\]. A more recent report on a patient who received eculizumab (a monoclonal antibody that blocks complement activation) and succumbed to disseminated cryptococcosis \[[@B30]\] may underscore the importance of the complement system in cryptococcal infection.

In summary, to improve the outcome in patients with decompensated cirrhosis with ascites, awareness of the immune dysfunction-related risk of invasive cryptococcosis is indispensable. Early diagnosis of cryptococcal infection and prompt introduction of antifungal agents are required for life-saving. For any end-stage cirrhotic patients, beta-D-glucan and cryptococcal antigen assays as well as culture with India ink staining of blood, ascites, or spinal fluid are highly recommended.
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![Computed tomography of the abdomen. Pleural effusion (a) and ascites (b) are seen. Within the liver, no abscess lesions were noted.](CRIHEP2018-5174518.001){#fig1}

![Cryptococci obtained from the blood culture. (a, b) Gram stain, (c) India ink stain, and (d) Grocott stain. The stains revealed characteristic budding-like features (a, d) and encapsulation (b, c) (original magnification, ×1000).](CRIHEP2018-5174518.002){#fig2}

###### 

Laboratory data on admission.

  **CBC**                                      **Hepatic**                        
  ---------------------------- --------------- --------------------------------- ------------
   WBC (3000-8500) /*µ*L       9200             CRP (0-0.29) mg/dL               9.68
                                                                                 
   Hb (11-16) g/dL             7.2              AST (13-37) U/L                  58
                                                                                 
   MCV (83-100) fL             119              ALT (8-45) U/L                   32
                                                                                 
   PLTs (150K-360K)/*µ*L       57K              LDH (122-228) U/L                362
                                                                                 
  **Hemostatic**                                ChE (206-477) U/L                25
                                                                                 
   PT (80-100)%                26.2             g-GTP (8-33) U/L                 23
                                                                                 
   PT-INR (0.9-1.1)            2.24             T. bil (0.3-1.3) mg/dL           6.68
                                                                                 
   APTT sec                    60.2             D. bil (0.1-0.3) mg/dL           4.70
                                                                                 
   APTT-control sec            28.1             Total protein (6.7-8.3) g/dL     4.4
                                                                                 
   Fibg (200-400) mg/dL        88               Albumin (4.1-5.2) g/dL           1.9
                                                                                 
   FDP (0.0-2.5) *µ*g/mL       16.8             Ammonia (20-70) *µ*g/dL          173
                                                                                 
   D-dimer (0.0-1.0) *µ*g/mL   10.2             Hyaluronic acid (0-50) ng/mL     41,112
                                                                                 
                                                Type IV collagen (0-140) ng/mL   872
                                                                                 
  **Renal & Electrolytes**                      Ceruloplasmin (21-37) mg/dL      14.1
                                                                                 
   BUN (7.8-18.9) mg/dL        48.7            **Viral studies**                  
                                                                                 
   Cre (0.45-0.82) mg/dL       3.97             HBs-Ag/HBs-Ab                    neg/pos
                                                                                 
   eGFR                        9                HBc-Ab                           pos (59.6)
                                                                                 
   UA (2.5-5.8) mg/dL          4.1              HCV-Ab                           neg
                                                                                 
   Na/ K/ Cl mmolL/L           141/ 5.2/ 105    HCV-core protein                 \<3
                                                                                 
  **Immunological**                             HIV                              neg
                                                                                 
   IgG (820-1740) mg/dL        851              HTLV-1                           neg
                                                                                 
   IgA (90-400) mg/dL          424             **Pleural fluid**                  
                                                                                 
   IgM (52-270) mg/dL          21               Cell counts; /*µ*L               272
                                                                                 
   C3 (80-140) mg/dL           44               Differential; mono %/ poly %     57.7/42.3
                                                                                 
   C4 (11-34) mg/dL            11.6             Protein; g/dL                    2.4
                                                                                 
   CH50 (30-45) U/mL           15               ADA (40-50) U/L                  17.1

Abbreviations for [Table 1](#tab1){ref-type="table"}.

WBC=white blood cell count, Hb=hemoglobin, MCV=mean corpuscular volume, PLTs=platelet counts, PT=prothrombin time, APTT=activated partial thromboplastin time, Fibg=fibrinogen, FDP=fibrin degradation product, BUN=blood urea nitrogen, Cre=creatinine, eGFR= estimated glomerular filtration rate, UA=uric acid, Ig=immunoglobulin, CH50=50% hemolytic unit of complement, C3=complement 3, C4=complement 4, CRP=C-reactive protein, AST=aspartate aminotransferase, ALT=alanine aminotransferase, LDH=lactate dehydrogenase, ChE=choline esterase, g-GTP=gamma-glutamyl transpeptidase, T. bil=total bilirubin, D. bil=direct bilirubin, HB=hepatitis B virus, Ag=antigen, Ab=antibody, HCV=hepatitis C virus, HIV=human immunodeficiency virus, HTLV-1= Human T-cell leukemia virus type 1, ADA=adenosine deaminase.

###### 

Cirrhosis-related cryptococcosis; Japanese experiences.

  ------------------------------------------------------------------------------------------------------------------------------------
       Reference        Age/Gender   Causes of liver cirrhosis   Symptoms                  Cryptococcal \   Treatment     Outcome \
                                                                                           infection                      (survival)
  ---- ---------------- ------------ --------------------------- ------------------------- ---------------- ------------- ------------
  1    Nakamura 2016    68/F         PBC                         fever                     peritonitis \    MCFG          Died \
                                                                                           fungemia                       (32 days)

  2    Haga 2015        59/M         HCV                         dyspnea \                 pulmonary, \     surgery       Died \
                                                                 PE                        MRSA                           (8 days)

  3    Hokari 2010      58/F         PBC                         diarrhea                  systemic         VCM           Died \
                                                                                                                          (16 days)

  4    Akiyama 2010     64/M         Alcohol                     seizure                   meningitis       AMPH-B \      Died \
                                                                                                            F-FLCZ        (23 days)

  5    Mitomi 2004      43/M         Alcohol                     headache \                meningitis       FLCZ \        Died \
                                                                 fever, \                                   AMPH-B        (57 days)
                                                                 general malaise                                          

  6    Touge 1999       60/M         HBV                         headache \                meningitis       FLCZ          Alive
                                                                 nausea                                                   

  7    Arata 1996       58/M         NA                          fever \                   pulmonary/ \     FLCZ          Alive \
                                                                 cavernous lung mass       meningitis                     (22 days+)

  8    Miyazaki 1993    70/M         HCV                         disturbed consciousness   meningitis       FCLZ          Alive

  9    Yoshizawa 1992   58/M         NA                          fever \                   fungemia \       antibiotics   Died
                                                                 dyspnea                   systemic                       

  10   Okazaki 1990     43/M         NA                          disturbed consciousness   systemic         NA            Died

  11   Yamamoto 1990    32/M         NA                          fever \                   meningitis       5-FC \        Alive
                                                                 headache \                                 MCZ           
                                                                 hematemesis                                              

  12   Present case     82/F         HBV                         general malaise \         fungemia         none          Died \
                                                                 hypotension \                                            (4 days)
                                                                 coma                                                     
  ------------------------------------------------------------------------------------------------------------------------------------

*Abbreviations.* PBC=primary biliary cirrhosis, HBV=hepatitis B virus, HCV=hepatitis C virus, NA=not available, PE=pleural effusion, MRSA= Methicillin-resistant Staphylococcus aureus, MCFG=Micafungin, VCM=Vancomycin, AMPH-B=Amphotericin-B, F-FLCZ= fosfluconazole, FLCZ= fluconazole, 5-FC= flucytosine, MCZ= miconazole.
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